As of Mar 27
| +0.01 / +0.27%|
The 1 analysts offering 12-month price forecasts for Genetic Technologies Ltd have a median target of 5.38, with a high estimate of 5.38 and a low estimate of 5.38. The median estimate represents a +45.34% increase from the last price of 3.70.
The current consensus among 1 polled investment analysts is to Buy stock in Genetic Technologies Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.